PPARG and neoplasm: Among the PPARs, PPARγ activation has been demonstrated to induce terminal differentiation and inhibit cell growth and inflammation in numerous malignant cell types and murine tumor models, suggesting that PPARγ agonists may act as tumor suppressors [16,18,20,37,38,39,40,41].